fingolimod hydrochloride has been researched along with alpha-aminopyridine in 2 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (alpha-aminopyridine) | Trials (alpha-aminopyridine) | Recent Studies (post-2010) (alpha-aminopyridine) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 5,813 | 460 | 3,246 |
Protein | Taxonomy | fingolimod hydrochloride (IC50) | alpha-aminopyridine (IC50) |
---|---|---|---|
Botulinum neurotoxin type A | Clostridium botulinum | 1.8 | |
Nitric oxide synthase, endothelial | Homo sapiens (human) | 2.8 | |
Nitric oxide synthase, brain | Homo sapiens (human) | 6 | |
Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 9 | |
Nitric oxide synthase, inducible | Homo sapiens (human) | 1.9 | |
Phosphatidylinositol 4-kinase alpha | Homo sapiens (human) | 7.1 | |
Phosphatidylinositol 4-kinase type 2-beta | Homo sapiens (human) | 7.1 | |
Phosphatidylinositol 4-kinase type 2-alpha | Homo sapiens (human) | 7.1 | |
Phosphatidylinositol 4-kinase beta | Homo sapiens (human) | 7.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ducruet, AF; Lawton, MT; Qiu, S; Sheth, KN; Shi, E; Shi, K | 1 |
Hiramoto, M; Hirota, A; Kazama, H; Miyazaki, M; Miyazawa, K; Ogawa, M; Ota, K; Suzuki, S; Takano, N | 1 |
2 other study(ies) available for fingolimod hydrochloride and alpha-aminopyridine
Article | Year |
---|---|
Chronic inflammation, cognitive impairment, and distal brain region alteration following intracerebral hemorrhage.
Topics: Aminopyridines; Animals; Brain; Cerebral Hemorrhage; Cognition; Cognitive Dysfunction; Disease Models, Animal; Fingolimod Hydrochloride; Flow Cytometry; Hippocampus; Inflammation; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroimaging; Neuronal Plasticity; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2019 |
Lysosome‑targeted drug combination induces multiple organelle dysfunctions and non‑canonical death in pancreatic cancer cells.
Topics: Aminopyridines; Antineoplastic Agents; Benzimidazoles; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Drug Synergism; Endoplasmic Reticulum Stress; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Lapatinib; Lysosomes; Pancreatic Neoplasms; Sphingosine 1 Phosphate Receptor Modulators | 2022 |